Clinical Roundup NEOSTAR phase II platform trial demonstrates neoadjuvant immunotherapy can enhance response in operable NSCLC March 17, 2023Vol.49 No.11
Clinical Roundup Study finds a cause of resistance to revumenib in acute leukemia March 17, 2023Vol.49 No.11
Clinical Roundup Healthy gut bacteria can help fight cancer in other parts of the body, UTSW researchers find March 17, 2023Vol.49 No.11
Clinical Roundup NEJM publishes phase III study of nirogacestat in adults with progressing desmoid tumors March 10, 2023Vol.49 No.10
Clinical Roundup SWOG study shows neoadjuvant Keytruda helps prevent recurrence in high-risk melanoma March 10, 2023Vol.49 No.10
Clinical Roundup Tagrisso demonstrated OS benefit in the ADAURA phase III trial for adjuvant treatment of early-stage EGFR-mutated lung cancer March 10, 2023Vol.49 No.10
Clinical Roundup Imfinzi significantly improved EFS in AEGEAN phase III trial for patients with resectable NSCLC March 10, 2023Vol.49 No.10
Clinical Roundup NCI Center for Cancer Research study identifies ecDNA as driver of SCLC March 10, 2023Vol.49 No.10
